Transcription of Treatment Breast Invasive Web Algorithm
{{id}} {{{paragraph}}}
Department of Clinical Effectiveness V16 Approved by Executive Committee of the Medical Staff on 09/15/2020 Page 1 of 24 Breast Cancer Invasive1 Stage I-III2 Disclaimer: This Algorithm has been developed for MD Anderson using a multidisciplinary approach considering circumstances particular to MD Anderson s specific patient population, services and structure, and clinical information. This is not intended to replace the independent medical or professional judgment of physicians or other health care providers in the context of individual clinical circumstances to determine a patient's care. This Algorithm should not be used to treat pregnant 2 Hormone receptor- 3 Hormone receptor-positive/HER2-positive or Hormone receptor- 4 Hormone receptor-negative/HER2-negative (triple negative Breast cancer).
Sep 15, 2020 · Note: Consider Clinical Trials as treatment options for eligible patients. SURGICAL CONSIDERATIONS1 Department of Clinical Effectiveness V16 Approved by Executive Committee of the Medical Staff on 09/15/2020 1 Patients with hereditary breast and ovarian cancer syndrome, deleterious BRCA1 and 2 mutations, history of chest wall radiation …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}